CA3294294A1 - Procédés d'utilisation d'inhibiteurs du facteur b - Google Patents

Procédés d'utilisation d'inhibiteurs du facteur b

Info

Publication number
CA3294294A1
CA3294294A1 CA3294294A CA3294294A CA3294294A1 CA 3294294 A1 CA3294294 A1 CA 3294294A1 CA 3294294 A CA3294294 A CA 3294294A CA 3294294 A CA3294294 A CA 3294294A CA 3294294 A1 CA3294294 A1 CA 3294294A1
Authority
CA
Canada
Prior art keywords
inhibitors
factor
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3294294A
Other languages
English (en)
Inventor
Eder JORG
Thomas Holbro
Rajesh Singh Karan
Bernd C. KIESEIER
Anna Svenja Schubart WELLENSIEK
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of CA3294294A1 publication Critical patent/CA3294294A1/fr
Pending legal-status Critical Current

Links

CA3294294A 2023-08-25 2024-08-23 Procédés d'utilisation d'inhibiteurs du facteur b Pending CA3294294A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63/578,694 2023-08-25
US63/668,430 2024-07-08

Publications (1)

Publication Number Publication Date
CA3294294A1 true CA3294294A1 (fr) 2025-03-06

Family

ID=

Similar Documents

Publication Publication Date Title
CA3264069A1 (fr) Inhibiteurs de kras
AU2024245542A1 (en) Kras inhibitors
AU2024349704A1 (en) Kras inhibitors
CA3294294A1 (fr) Procédés d'utilisation d'inhibiteurs du facteur b
CA3283726A1 (fr) Procédés d'utilisation d'inhibiteurs du facteur b
HK40128702A (en) Methods of using factor b inhibitors
CA3289184A1 (fr) Inhibiteurs hétéroarylindoles d'apol-1
IL326113A (en) Methods of using factor B inhibitors
CA3280853A1 (fr) Inhibiteurs de l'expression de synaptogyrine-3
AU2024229868A1 (en) Inhibitors of lrrk2
CA3301214A1 (fr) Inhibiteurs de pcsk9
CA3293535A1 (fr) Inhibiteurs de tyk2
CA3273897A1 (fr) Inhibiteurs de tyk2
AU2023902842A0 (en) Methods of inhibiting hGIIA
HK40126500A (en) Solid forms of complement factor b inhibitors
CA3272523A1 (fr) Formes solides d'inhibiteurs du facteur b du complément
CA3299341A1 (fr) Inhibiteurs de parp7
HK40130936A (en) Vanin-1 inhibitors
CA3286215A1 (fr) Inhibiteurs de vanine-1
CA3279779A1 (fr) Inhibiteurs de prmt5-mta
HK40128988A (zh) 抑制剂
HK40120615A (en) Parp7 inhibitors
CA3273444A1 (fr) Inhibiteurs de rock2
HK40122640A (en) Inhibitors of rock2
CA3280616A1 (fr) Nouveaux inhibiteurs d'alpk1